Winson Machinery Co., Ltd. logo

Winson Machinery Co., Ltd. (4538)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
17. 45
-0.05
-0.2857%
NT$
- Market Cap
- P/E Ratio
90% Div Yield
17,000 Volume
- Eps
NT$ 17.5
Previous Close
Add Transaction
Day Range
17.4 17.65
Year Range
16.4 19.95
Want to track 4538 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4538 closed today lower at NT$17.45, a decrease of -0.2857% from yesterday's close, completing a monthly decrease of -7.672% or -NT$1.45. Over the past 12 months, 4538 stock gained 2.6471%.
4538 pays dividends to its shareholders, with the most recent payment made on Jun 25, 2026. The next estimated payment will be in In 10 months on Jun 25, 2027 for a total of NT$1.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Winson Machinery Co., Ltd. has completed 4 stock splits, with the recent split occurring on Aug 15, 2023.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).

4538 Chart

Winson Machinery Co., Ltd. (4538) FAQ

What is the stock price today?

The current price is NT$17.45.

On which exchange is it traded?

Winson Machinery Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4538.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 90%.

What is its market cap?

As of today, no market cap data is available.

Has Winson Machinery Co., Ltd. ever had a stock split?

Winson Machinery Co., Ltd. had 4 splits and the recent split was on Aug 15, 2023.

Winson Machinery Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
TWSE Exchange
TW0004538004 ISIN
Japan Country
1,370 Employees
29 Sep 2026 Last Dividend
28 Sep 2016 Last Split
- IPO Date

Overview

Fuso Pharmaceutical Industries, Ltd. is a prominent manufacturer and distributor of pharmaceuticals and medical equipment in Japan. Since its incorporation in 1937, Fuso Pharmaceutical has been committed to the development, production, and sales of high-quality healthcare products. Headquartered in Osaka, Japan, the company not only focuses on the Japanese market but also extends its services to contract manufacturing of drugs for other companies, alongside running a real estate leasing business. This diversified approach allows Fuso Pharmaceutical to leverage its expertise in pharmaceuticals while exploring new business avenues.

Products and Services

  • Injectables: Fuso Pharmaceutical Industries provides a range of injectable drugs that are used for various medical conditions. These injectables are designed for use in hospitals and clinics, ensuring high-quality standards for patient care.
  • Infusions: The company offers infusion solutions that are essential in healthcare for hydrating patients or administering drugs intravenously. These products cater to a broad spectrum of clinical needs, from basic electrolyte replenishment to specialized nutrient mixtures.
  • Dialysis Agents for Artificial Kidneys: Specializing in nephrology, Fuso Pharmaceutical manufactures dialysis agents used in artificial kidney machines. These agents help in the dialysis process by cleaning the blood of patients with kidney failure or reduced kidney function.
  • Medical Equipment and Devices: Beyond pharmaceuticals, Fuso also develops and sells an array of medical equipment and devices. This diversification into medical technology enables the company to support healthcare providers with tools that enhance patient treatment and care.
  • Contract Manufacturing of Drugs: Fuso Pharmaceutical offers contract manufacturing services, utilizing its extensive experience and infrastructure to manufacture drugs on behalf of other pharmaceutical companies. This allows Fuso to leverage its manufacturing capabilities to meet the needs of a global clientele.
  • Real Estate Leasing: Expanding its business operations, Fuso Pharmaceutical engages in real estate leasing, including properties that can be utilized for a range of purposes. This segment of their business allows for a steady stream of revenue outside their primary focus on pharmaceuticals and medical devices.

Contact Information

Address: 2-3-11, Morinomiya
Phone: 81 6 6969 1131